-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -0,48 % | -13,75 % | -5,05 % | -16,53 % | -26,07 % | 132,32 % | - |
| Vaxart Inc. | -0,34 % | 0,97 % | -16,76 % | -50,43 % | -56,97 % | -76,10 % | -94,63 % |
| Larimar Therapeutics Inc. | 0,00 % | 4,70 % | -7,69 % | -47,12 % | -16,13 % | 4,70 % | -80,69 % |
News
This AI Stock Hasn't Caught Up to Its Fundamentals Yet. Is the Market Sleeping on It?
Most investors considering artificial intelligence (AI) stocks gravitate toward big names such as Nvidia, Broadcom, Advanced Micro Devices, and hyperscalers building large AI clusters. However
Can AMD Be a Trillion-Dollar Company?
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.
Why Micron and SK Hynix Could Quietly Become the Real AI Winners
Investors who are looking for high-potential artificial intelligence (AI) stocks often pick well-known semiconductor players such as Nvidia and Advanced Micro Devices, hyperscalers such as Amazon


